Equities research analysts at StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Stock Performance Shares of NASDAQ:ONTX opened at $0.67 on Tuesday. Onconova Therapeutics has a 1 year low of $0.55 […]
StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance Shares of ONTX opened at $0.70 on Monday. Onconova Therapeutics has a one year low of $0.55 and a […]
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 price target on shares of Onconova Therapeutics in a research note on […]
Research analysts at StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $11.00 price objective on shares of Onconova Therapeutics in a report on […]
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a report released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Onconova Therapeutics in a research report on Thursday, October 12th. […]